Cargando…
Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients Treatment
The gut-brain axis (GBA) refers to the multifactorial interactions between the intestine microflora and the nervous, immune, and endocrine systems, connecting brain activity and gut functions. Alterations of the GBA have been revealed in people with multiple sclerosis (MS), suggesting a potential ro...
Autores principales: | Dziedzic, Angela, Saluk, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699268/ https://www.ncbi.nlm.nih.gov/pubmed/36430954 http://dx.doi.org/10.3390/ijms232214478 |
Ejemplares similares
-
Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020) -
Probiotic and commensal gut microbial therapies in multiple sclerosis and its animal models: a comprehensive review
por: Blais, Lorrie L., et al.
Publicado: (2021) -
Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis
por: Saluk-Bijak, Joanna, et al.
Publicado: (2019) -
A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis
por: Miller, Elzbieta Dorota, et al.
Publicado: (2019) -
The GPR17 Receptor—A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)